Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review von van Nieuw Amerongen, M. P., de Grooth, H. J., Veerman, G. L., Ziesemer, K. A., van Berge Henegouwen, M. I., Tuinman, P. R.

Volltext

ASO Author Reflections: Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review von van Nieuw Amerongen, M. P., de Grooth, H. J., Veerman, G. L., Ziesemer, K. A., van Berge Henegouwen, M. I., Tuinman, P. R.

Volltext

Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimert... von Veerman, G.D. Marijn, Lam, Mei H., Mathijssen, Ron H.J., Koolen, Stijn L.W., de Bruijn, Peter

Volltext

‘Traffic-light’ nutrition labelling and ‘junk-food’ tax: a modelled comparison of cost-effectiveness for obesity prevention von Sacks, G, Veerman, J.L, Moodie, M, Swinburn, B

Volltext

Clinical implications of food–drug interactions with small-molecule kinase inhibitors von Veerman, G D Marijn, Hussaarts, Koen G A M, Jansman, Frank G A, Koolen, Stijn W L, van Leeuwen, Roelof W F, Mathijssen, Ron H J

Volltext

Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin von Veerman, Rosanne E., Teeuwen, Loes, Czarnewski, Paulo, Güclüler Akpinar, Gözde, Sandberg, AnnSofi, Cao, Xiaofang, Pernemalm, Maria, Orre, Lukas M., Gabrielsson, Susanne, Eldh, Maria

Volltext

Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS von de Leeuw, Simon P., de Bruijn, Peter, Koolen, Stijn L.W., Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Veerman, G.D. Marijn

Volltext

Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment von Holleman, Amy, Cheok, Meyling H, den Boer, Monique L, Yang, Wenjian, Veerman, Anjo J.P, Kazemier, Karin M, Pei, Deqing, Cheng, Cheng, Pui, Ching-Hon, Relling, Mary V, Janka-Schaub, Gritta E, Pieters, Rob, Evans, William E

Volltext

The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia von Zuurbier, Linda, Petricoin, 3rd, Emanuel F, Vuerhard, Maartje J, Calvert, Valerie, Kooi, Clarissa, Buijs-Gladdines, Jessica G C A M, Smits, Willem K, Sonneveld, Edwin, Veerman, Anjo J P, Kamps, Willem A, Horstmann, Martin, Pieters, Rob, Meijerink, Jules P P

Volltext

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer von Veelen, Ard, Veerman, G. D. Marijn, Verschueren, Marjon V., Gulikers, Judith L., Steendam, Christi M. J., Brouns, Anita J. W. M., Dursun, Safiye, Paats, Marthe S., Tjan‐Heijnen, Vivianne C. G., Leest, Cor, Dingemans, Anne‐Marie C., Mathijssen, Ron H. J., Garde, Ewoudt M. W., Souverein, Patrick, Driessen, Johanna H. M., Hendriks, Lizza E. L., Geel, Robin M. J. M., Croes, Sander

Volltext

Comparing periodontitis biomarkers in saliva, oral rinse and gingival crevicular fluid: A pilot study von Katsiki, Panagiota, Nazmi, Kamran, Loos, Bruno G., Laine, Marja L., Schaap, Kim, Hepdenizli, Esen, Bikker, Floris J., Brand, Henk S., Veerman, Enno C.I., Nicu, Elena A.

Volltext

NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or... von Zuurbier, L, Homminga, I, Calvert, V, Winkel, ML te, Buijs-Gladdines, J G C A M, Kooi, C, Smits, W K, Sonneveld, E, Veerman, A J P, Kamps, W A, Horstmann, M, Petricoin, E F, Pieters, R, Meijerink, J P P

Volltext

Improving the tolerability of osimertinib by identifying its toxic limit von Agema, Bram C., Veerman, G. D. Marijn, Steendam, Christi M. J., Lanser, Daan A. C., Preijers, Tim, van der Leest, Cor, Koch, Birgit C. P., Dingemans, Anne-Marie C., Mathijssen, Ron H. J., Koolen, Stijn L. W.

Volltext

On the ecosystemic network of saliva in healthy young adults von Zaura, Egija, Brandt, Bernd W, Prodan, Andrei, Teixeira de Mattos, Maarten Joost, Imangaliyev, Sultan, Kool, Jolanda, Buijs, Mark J, Jagers, Ferry LPW, Hennequin-Hoenderdos, Nienke L, Slot, Dagmar E, Nicu, Elena A, Lagerweij, Maxim D, Janus, Marleen M, Fernandez-Gutierrez, Marcela M, Levin, Evgeni, Krom, Bastiaan P, Brand, Henk S, Veerman, Enno CI, Kleerebezem, Michiel, Loos, Bruno G, van der Weijden, G A, Crielaard, Wim, Keijser, Bart JF

Volltext

To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry von Veerman, G.D. Marijn, de Bruijn, Peter, Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Koolen, Stijn L.W.

Volltext

The influence of green tea extract on nintedanib’s bioavailability in patients with pulmonary fibrosis von Veerman, G.D.Marijn, van der Werff, Sanne C., Koolen, Stijn L.W., Miedema, Jelle R., Oomen-de Hoop, Esther, van der Mark, Sophie C., Chandoesing, Prewesh P., de Bruijn, Peter, Wijsenbeek, Marlies S., Mathijssen, Ron H.J.

Volltext

Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1000-fold von Oudhoff, Menno J, Kroeze, Kim L, Nazmi, Kamran, van den Keijbus, Petra A.M, van 't Hof, Wim, Fernandez-Borja, Mar, Hordijk, Peter L, Gibbs, Susan, Bolscher, Jan G.M, Veerman, Enno C.I

Volltext

Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane von den Hertog, Alice L, van Marle, Jan, van Veen, Henk A, Van't Hof, Wim, Bolscher, Jan G M, Veerman, Enno C I, Nieuw Amerongen, Arie V

Volltext

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application von Braal, C. Louwrens, Veerman, G.D. Marijn, Peric, Robert, Aerts, Joachim G.J.V., Mathijssen, Ron H.J., Koolen, Stijn L.W., de Bruijn, Peter

Volltext

Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma von Steendam, Christi M.J., Peric, Robert, van Walree, Nico C., Youssef, Magdolen, Schramel, Franz M.N.H., Brocken, Pepijn, van Putten, John W.G., van der Noort, Vincent, Veerman, G.D. Marijn, Koolen, Stijn L.W., Groen, Harry J.M., Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Smit, Egbert F., Aerts, Joachim G.J.V.

Volltext